Chronic Migraine Clinical Trial
Official title:
Impact of a Nursing Intervention on the Clinical Evolution of Patients at a University Migraine Clinic
Headache disorders are prevalent, disabling, under recognized, under diagnosed and under
treated. Migraine has a prevalence of 10% in men and 25% in women in Canada. The treatment
of migraine is based on patient education (lifestyle habit modification, trigger avoidance),
and pharmacological acute treatment and prophylaxis. A multidisciplinary approach allows a
repartition of tasks between different health professionals.
In a 2010 meeting, the Canadian Headache Society members supported the concept of Headache
Centers, and a headache nurse was judged as an essential component of such centers.
Gaul has reviewed the structured multidisciplinary approach that could be used in a headache
centre and the existing studies using such structures. Five studies did include a headache
nurse. No study did observe the impact of a nurse only. Resources in medical care are
limited. One study did use a program of 96 hours, which does not seem realistic on the
long-term and for a large pool of patients in a public hospital. Patients are not always
able to pay for paramedical help such as physiotherapy and psychotherapy. Even if they do,
finding a specialized therapist for chronic headache is difficult. Defining the role of a
nurse and demonstrating the impact on patient care is therefore a first step in the concept
of a headache center. Possible roles of a headache nurse according to Gaul are patient
education, follow-up of the treatment plan, addressing patient queries, and monitoring of
patient progress. The headache nurse may also participate in research projects. In a
hospital Headache Clinic, the nurse may be involved in intra-venous treatments and blood
sampling for research.
In summary, evidence to demonstrate the impact of a nurse in a headache clinic is lacking.
We propose to study this aspect prospectively. A study with positive findings would
encourage health ministers to fund and support headache nurses for headache centers across
Canada for headache management. Chronic headache and therefore chronic migraine would be a
focus of such centers, since most patients seen in specialized centers are chronic.
HYPOTHESIS: The addition of a headache nurse to the headache team will help the CHUM
Migraine Clinic to improve treatment outcome, and reduce the burden of headache. This
multidisciplinary approach will also allow a higher efficiency of the team.
STUDY DESIGN:
The goal of this study is to compare two treatment approaches for migraineurs. The first
approach will be based on the physician only and is limited to fixed appointments (control
group). The second approach will be based on a team involving a headache nurse (active
group) who will participate in patient education and follow-up. The goal is to improve
patient outcome but also physician productivity.
First 100 patients (control group, phase 1): patients with episodic and chronic migraine
will be screened, sign consent and be enrolled. They will be seen by the physician only,
without the nurse's support. This situation will reproduce the actual conditions at the
clinic. During this phase, the nurse will be involved in the follow-up of known patients
(who will not be included in the protocol) and data collection. She will develop her
headache management abilities and help the physicians to develop some educational tools for
patients.
Following 100 patients (active group, phase 2) : patients with episodic and chronic migraine
will be screened and enroled. They will be seen by the physician and nurse team, with a
treatment plan tailored to specific needs including regular scheduled visits, follow-up of
chronification factors and educational sessions. Phone call follow-ups will be planned.
Patients will have an easier and quicker contact with the team in an emergency situation.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05720819 -
Biofeedback-VR for Treatment of Chronic Migraine
|
N/A | |
Not yet recruiting |
NCT06428838 -
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
|
Phase 3 | |
Recruiting |
NCT05517200 -
Pilot Study for a Machine Learning Test for Migraine
|
||
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Completed |
NCT02514148 -
Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients
|
N/A | |
Enrolling by invitation |
NCT02291380 -
A Study to Evaluate Botulinum Toxin Type A for Injection(HengLi®)for Prophylactic Treatment of Chronic Migraine
|
Phase 3 | |
Withdrawn |
NCT02122744 -
RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine
|
N/A | |
Completed |
NCT02122237 -
Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial
|
Phase 3 | |
Recruiting |
NCT02202486 -
Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
|
N/A | |
Completed |
NCT01709708 -
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
|
Phase 4 | |
Completed |
NCT01741246 -
Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging
|
N/A | |
Completed |
NCT01090050 -
Treximet in the Treatment of Chronic Migraine
|
Phase 4 | |
Recruiting |
NCT03507400 -
Introvision for Migraine and Headaches
|
N/A | |
Completed |
NCT04161807 -
Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine
|
N/A | |
Completed |
NCT03175263 -
OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain
|
N/A | |
Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
Completed |
NCT01667250 -
Non-Invasive Neurostimulation for the Prevention of Chronic Migraine
|
N/A | |
Completed |
NCT01700387 -
A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency
|
Phase 4 | |
Not yet recruiting |
NCT01135784 -
Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache
|
Phase 2 | |
Completed |
NCT00772031 -
NINDS CRC Chronic Migraine Treatment Trial
|
Phase 3 |